Celerion

Celerion, a leader in early clinical research services and clinical bioanalysis, is a global company with over 50 years of experience. Our unique combination of medical expertise, clinical operations experience and scientific excellence provides our customers with the guidance to make fast, accurate decisions about their drug development. Celerion has proven experience across a variety of vaccines, including different routes of administration, and patient populations. Our track record spans both preventive and therapeutic vaccines, subunit, and conjugates across all phases I-IV in more than 20 countries, 300 study centers and 4500 subjects.